Home > Riviste > Minerva Gastroenterologica e Dietologica > Fascicoli precedenti > Minerva Gastroenterologica e Dietologica 2015 June;61(2) > Minerva Gastroenterologica e Dietologica 2015 June;61(2):101-15

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

MINERVA GASTROENTEROLOGICA E DIETOLOGICA

Rivista di Gastroenterologia, Nutrizione e Dietetica


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

REVIEW  


Minerva Gastroenterologica e Dietologica 2015 June;61(2):101-15

Copyright © 2015 EDIZIONI MINERVA MEDICA

lingua: Inglese

The current state of surgery for pancreatic cancer

Poruk K. E., Weiss M. J.

Department of Surgery The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA


PDF  


Pancreatic adenocarcinoma (PDAC) is the fourth leading cause of cancer mortality in the United States, with a dismal 5-year survival of only 6% for all stages. Surgical resection offers the best opportunity for prolonged survival at this time, but is limited to patients with locally resectable tumors and no distant metastases. Although only 10-20% of patients present with early stage disease are amenable to surgical resection, remarkable advancements have been made over the past several decades leading to improved morbidity and mortality after pancreatic resection. This article will review the current state of pancreatic surgery including its role in the multidisciplinary approach to pancreatic cancer treatment, advances and controversies in surgical technique, and the limitations of surgical therapy that will need to be addressed in the future to improve survival for patients with pancreatic cancer.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

mweiss5@jhmi.edu